Qrons Inc. (OTCQB:QRON) announced that the USPTO granted U.S. Patent No. 10,954,315 to Dartmouth College, covering 3-D printing materials. This patent results from Qrons' collaboration with Professor Chenfeng Ke since July 2018, focused on developing 3D printable hydrogels for its stem cell-based treatments for traumatic brain injuries. The exclusive license from Dartmouth allows Qrons to leverage these advancements in its biotech innovations. CEO Jonah Meer emphasized the importance of this step in enhancing Qrons' technological foundation.
Qrons Inc. (OTCQB:QRON) has launched a newly redesigned website aimed at enhancing public education on its expanded focus in treating neuronal diseases beyond traumatic brain injury (TBI). The website reflects Qrons' synergy of tissue engineering, stem cells, and machine learning technologies. CEO Jonah Meer expressed enthusiasm over leveraging proprietary knowledge and collaboration with Israeli biotech ventures. The new site will enable more flexible updates for future developments and reflects the company's commitment to innovative biotechnology solutions.